BioTech 365

AUGUST 10, 2020

Company Provides COVID-19 Update KENNETT SQUARE, Pa., 10, 2020 (GLOBE NEWSWIRE) — Genesis Healthcare, Inc. Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results for the second quarter … Continue reading →

40

40

The Pharma Data

DECEMBER 1, 2020

–( BUSINESS WIRE )– Genesis Therapeutics , a company pioneering AI technologies to create medicines for patients with severe and unmet medical needs, has completed its $52M Series A financing round. Most recently, Genesis announced a multi-target partnership with Genentech. Genesis’ CEO and co-founder. “We

Development 40

Development Drugs Engineer FDA Approval 40

Pharmaceutical Technology

JUNE 4, 2023

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.

Antibody 130

Antibody Gene Research Development 130

Pharmaceutical Technology

JUNE 4, 2023

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.

Genetics 130

Genetics Gene Expression DNA Antibody 130

Drug Discovery World

NOVEMBER 18, 2022

The annual Genesis conference will take place on 7 December 2022 in London, and 5,6 and 8 December online, bringing key opinion leaders, investors and innovators from across the life sciences sector under one roof to exchange insights, debate trends and generate deals. Registration is still possible at www.genesisconference.com.

Life Science 52

Life Science Big Data Drugs Clinical Trials 52

BioTech 365

OCTOBER 7, 2020

NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the launch of its new O-GENESIS™ Graft Delivery System during the North American Spine Society (NASS) 2020 virtual annual meeting. LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc.

52

52

The Pharma Data

DECEMBER 9, 2020

It will if the following five companies, which all launched this year with Series A financing, have anything to say about it. . His company, which also includes Qiuqing Ang , M.D., Genesis Therapeutics. Genesis went public on December 2 in a round of $52 million Series A financing led by Rock Springs Capital.

Marketing 52

Marketing In-Vivo Protein In-Vitro 52

pharmaphorum

DECEMBER 11, 2020

The companies said that the combination will strengthen their offering to pharmaceutical and biotech companies. The combined company will deliver data analytics, insights, business intelligence, virtual patient visits and hybrid technological solutions. .

Trials 60

Trials Development Vaccination Vaccine 60

Drug Discovery World

OCTOBER 27, 2022

Johnson-Kent introduced the notion of the zebra company and compared its two-fold purpose of profitability and societal advancement to the cell and gene therapy industry. What are zebra companies? The drug discovery industry is familiar with unicorn companies, but what about zebra companies?

Medicine 52

Medicine Gene Therapy Gene Manufacturing 52

pharmaphorum

FEBRUARY 24, 2021

The health economic component of the revamped IPTs is informed by guidelines from the Grupo de Evaluación de Novedades, EStandarización e Investigación en Selección de Medicamentos (Group for the Evaluation of Innovations, Standardisation and Research in Drug Selection, GENESIS).

Marketing 80

Marketing Pharmacy Medicine Branding 80

pharmaphorum

FEBRUARY 4, 2021

As COVID cases surged last year, lung cancer referrals dropped in the UK, causing alarm to the UK Lung Cancer Coalition (UKLCC), an alliance of the UK’s leading lung cancer experts, senior NHS professionals, charities, and healthcare companies.

Development 133

Development 133

Drug Discovery World

JANUARY 2, 2024

She noted that while companies like Moderna and BioNTech are focused on mRNA platforms, those that used the more classical viral platform are now thinking about how to enter the space. He noted that historically, you either had therapeutics or non-therapeutics companies. BioNTech is also working in this space.

Research 59

Research Vaccination Vaccine Medicine 59

XTalks

FEBRUARY 24, 2021

Xtalks profiled the Droplet Micron needle in a previous article , but later had the chance to speak to specialists from the company to learn more about the device. And this was what led to the genesis of the company. Ward says this “know-how-ness is very rare and only a few companies in the world know how to do [it].”.

Insulin 64

Insulin Production Drug Delivery Marketing 64

XTalks

APRIL 25, 2024

Devices pending FDA approval like Genesis MedTech’s J-Valve Transfemoral (TF) System and JenaValve Technology’s Trilogy Transcatheter Heart Valve (THV) System have introduced innovative design features tailored to overcome the obstacles inherent in treating regurgitation.

Development 111

Development Trials Clinical Trials Clinical Trials 111

pharmaphorum

MARCH 3, 2022

They will use drug substance made by GeneSys Biologics but will be made at Civica’s manufacturing plant in Petersburg, Virgina, which is currently under construction and due to come online in early 2024. Cheaper options are meanwhile becoming available.

Insulin 52

Insulin Production Generic Drugs FDA Approval 52

Druggist

SEPTEMBER 7, 2020

In fact, the products listed below are made by the same company (Omega Pharma Ltd), which makes Nytol One A Night. Phenergan alternative products Generic promethazine 10mg tablets Promethazine 10mg tablets are available as pharmacy-only medication in a ‘generic’ form (Genesis Pharmaceuticals).

Containment 94

Containment Pharmacy Licensing Licensing 94

The Pharma Data

DECEMBER 15, 2020

Company plans to meet with regulatory authorities as it evaluates next development steps. Company to host Key Opinion Leader (KOL) webinar to discuss these results today, December 16, at 8:00 am EST; registration link below. TEL AVIV, Israel , Dec. 16, 2020 /PRNewswire/ — BioLineRx Ltd. .

Clinical Trials 52

Clinical Trials Clinical Trials Trials Development 52